Thromboprophylaxis in Acutely Ill Medical Patients: Results of A Survey Among Italian Physicians

被引:3
|
作者
Dentali, Francesco [1 ]
Pomero, Fulvio [2 ]
La Regina, Micaela [3 ]
Orlandini, Francesco [3 ]
Turato, Sara [1 ]
Mazzone, Antonino [4 ]
Nozzoli, Carlo [5 ]
Fontanella, Andrea [6 ]
Ageno, Walter [1 ]
Agnelli, Giancarlo [7 ]
Campanini, Mauro [8 ]
机构
[1] Insubria Univ, Dept Clin Med, I-21100 Varese, Italy
[2] ASO S Croce E Carle, Dept Clin Med, Cuneo, Italy
[3] Presidio Ospedaliero Unico Levante Ligure, Dept Internal Med, La Spezia, Italy
[4] AO Osped Civile, Dept Internal Med, Legnano, Italy
[5] AO Careggi, Dept Internal Med, Florence, Italy
[6] Osped Buon Consiglio, Dept Internal Med, Naples, Italy
[7] Univ Perugia, Internal & Cardiovasc Med & Stroke Unit, I-06100 Perugia, Italy
[8] AOU Maggiore Carita, Dept Internal Med, Novara, Italy
关键词
venous thromboembolism; bleeding risk; thromboprophylaxis; RAMs; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; BLEEDING RISK; PREVENTION; ENOXAPARIN; COMPRESSION; MULTICENTER; VALIDATION;
D O I
10.1016/j.thromres.2014.06.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: acutely ill medical patients are at increased risk of venous thromboembolism (VTE) and often require thromboprophylaxis, but patient selection and adequate therapeutic decisions may be difficult due to the heterogeneity and the complexity of this population. We conducted a survey among a large cohort of Italian physicians to assess their approach to some important "grey" areas of VTE prevention in this setting. Methods: a questionnaire was distributed during the meeting of a national society of Internal Medicine (FADOI), held in May 2013. Four clinical scenarios describing areas of clinical uncertainty were administered to participants: the first on a patient with acute ischemic stroke; the second on a patient with severe renal insufficiency; the third on the duration of prophylaxis in the post-acute setting; and the last on a patient at high risk of VTE and at moderate risk of bleeding with preserved mobility. Results: 453 questionnaires were returned (participants mean age 48.5 years). About 70% of participants systematically assess VTE and bleeding risk in their clinical practice, but a minority of them use risk assessment models. Prolonged prophylaxis in the post-acute setting was voted by more than eighty percent of participants; replies to the other three clinical scenarios were more heterogeneous with none of the options selected by more than 60% of participant. Conclusion: physicians approach to "grey" areas of antithrombotic prophylaxis in the medical setting is quite heterogeneous and sometimes partially in contrast to recent guidelines, reinforcing the need for educational programs and high quality studies in this setting. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 50 条
  • [21] Comparative effectiveness of thromboprophylaxis in acutely ill medical patients across the US acute hospital setting
    Huang, W.
    Anderson, F. A.
    Cohen, A. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 749 - 749
  • [22] Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
    Alexander Thomas Cohen
    Theodore Erich Spiro
    Harry Roger Büller
    Lloyd Haskell
    Dayi Hu
    Russell Hull
    Alexandre Mebazaa
    Geno Merli
    Sebastian Schellong
    Alex Spyropoulos
    Victor Tapson
    Journal of Thrombosis and Thrombolysis, 2011, 31 : 407 - 416
  • [23] The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis
    Marszalek, Jolanta
    Mehrsefat, Sara
    Chi, Gerald
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (08) : 679 - 684
  • [24] Survey of prophylaxis against venous thromboembolism in acutely ill medical patients
    Peterman, CM
    Kolansky, D
    Spinler, S
    PHARMACOTHERAPY, 2004, 24 (10): : 1424 - 1425
  • [25] Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
    Nanna Freund
    Jonas E. Sabroe
    Peter Bytzer
    Søren M. Madsen
    Advances in Therapy, 2018, 35 : 1873 - 1883
  • [26] Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
    Freund, Nanna
    Sabroe, Jonas E.
    Bytzer, Peter
    Madsen, Soren M.
    ADVANCES IN THERAPY, 2018, 35 (11) : 1873 - 1883
  • [27] Contemporary adequacy of thromboprophylaxis in acutely ill medical patients in Switzerland: a bi-centric prospective cohort
    Marando, Marco
    Blondon, Katherine
    Farhoumand, Pauline Darbellay
    Nendaz, Mathieu
    Grauser, Damien
    Sallet, Alain
    Tamburello, Adriana
    Pons, Marco
    Righin, Marc
    Gianella, Pietro
    Blondon, Marc
    SWISS MEDICAL WEEKLY, 2023, 153
  • [28] Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)
    Louzada, Martha L.
    Al-Ani, Fatimah
    Kovacs, Michael J.
    Siqueira, Lenicio
    Lazo-Langner, Alejandro
    BLOOD, 2015, 126 (23)
  • [29] Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials
    Weitz, Jeffrey I.
    Raskob, Gary E.
    Spyropoulos, Alex C.
    Spiro, Theodore E.
    De Sanctis, Yoriko
    Xu, Jianfeng
    Lu, Wentao
    Suh, Eunyoung
    Argenti, Domenick
    Yang, Haitao
    Albanese, John
    Lipardi, Concetta
    Barnathan, Elliot S.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (03) : 515 - 524
  • [30] Betrixaban in Acutely Ill Medical Patients
    Patil, Rucha
    Ghosh, Kanjaksha
    Shetty, Shrimati
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (24):